GlassScriptPhysician profile
Thomas A Fortney
NPI 1386006591
$54,098.64
in general payments reported to CMS, 2019-2025
18 companies · $2,413 in 2025
The $2,413 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,554 · 2022: $47K · 2023: $969 · 2024: $1,272 · 2025: $2,413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,971 · Travel and Lodging: $1,546 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,970.80 |
| Travel and Lodging | $1,545.59 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $36,590.91 | 2022 | |
| Arthrex, INC. | $4,191.11 | 2022-2024 | |
| Gotham Surgical Solutions & Devices, INC. | $3,885.33 | 2021-2022 | |
| Stryker Corporation | $3,304.44 | 2022-2025 | Mako, Blueprint Patient Specific Instrumentation, Aequalis Flex Revive |
| Kairos Surgical INC | $2,616.47 | 2021-2025 | |
| Medical Device Business Services, INC. | $1,966.76 | 2022-2025 | Stratafix |
| Zimmer Biomet Holdings, INC. | $710.42 | 2022-2025 | Tapestry, Comprehensive Shoulder System, Gel-One Cross-Linked Hyaluronate |
| Medacta USA, INC. | $196.21 | 2025 | Nextar Rsa Platform, Gmk Sphere |
| Miach Orthopaedics, INC. | $102.93 | 2023 | |
| Ethicon US, LLC | $94.60 | 2025 | Stratafix, Vistaseal, Ethicon |
| Bioventus LLC | $79.11 | 2023-2024 | Exogen Ultrasound Bone Healing System, Durolane |
| Skeletal Dynamics INC | $78.11 | 2025 | Implate, Geminus, Align |
| Orthofix Medical, INC. | $69.61 | 2022-2024 | Physio-Stim |
| Pacira Pharmaceuticals Incorporated | $66.20 | 2022-2024 | Iovera, Zilretta, Exparel |
| Depuy Synthes Sales INC. | $55.97 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $51.97 | 2024-2025 | |
| Powerlink Ai, INC. | $24.23 | 2025 | |
| Janssen Biotech, INC. | $14.26 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Fortney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.